Pedram Argani

35.8k total citations · 3 hit papers
311 papers, 24.6k citations indexed

About

Pedram Argani is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Pedram Argani has authored 311 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Pulmonary and Respiratory Medicine, 153 papers in Molecular Biology and 99 papers in Oncology. Recurrent topics in Pedram Argani's work include Renal and related cancers (113 papers), Renal cell carcinoma treatment (109 papers) and Sarcoma Diagnosis and Treatment (42 papers). Pedram Argani is often cited by papers focused on Renal and related cancers (113 papers), Renal cell carcinoma treatment (109 papers) and Sarcoma Diagnosis and Treatment (42 papers). Pedram Argani collaborates with scholars based in United States, Italy and Canada. Pedram Argani's co-authors include Marc Ladanyi, Jonathan I. Epstein, Saraswati Sukumar, Victor E. Reuter, Ralph H. Hruban, Cristina R. Antonescu, George J. Netto, Robert B. West, Miao-Chih Tsai and Howard Y. Chang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Pedram Argani

305 papers receiving 24.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

2010 4.2k citations Pedram Argani et al. profile →
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

2013 738 citations Pedram Argani et al. The American Journal of Surgical Pathology profile →
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis

2003 504 citations Anirban Maitra, Pedram Argani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedram Argani United States	80	14.3k	11.4k	8.6k	6.4k	4.2k	311	24.6k
Yoshinao Oda Japan	64	6.3k 0.4×	7.7k 0.7×	2.8k 0.3×	8.7k 1.3×	4.4k 1.1×	948	20.4k
John N. Eble United States	69	9.4k 0.7×	10.5k 0.9×	3.9k 0.5×	2.8k 0.4×	4.8k 1.1×	290	17.2k
Jonathan A. Fletcher United States	75	7.2k 0.5×	11.0k 1.0×	2.5k 0.3×	5.5k 0.9×	4.5k 1.1×	203	23.4k
Alexander J. Lazar United States	77	6.5k 0.5×	9.2k 0.8×	2.9k 0.3×	8.9k 1.4×	1.8k 0.4×	448	21.1k
Noel Weidner United States	49	8.8k 0.6×	4.3k 0.4×	5.5k 0.6×	5.4k 0.8×	2.3k 0.5×	183	17.9k
Timothy J. Triche United States	70	7.4k 0.5×	7.8k 0.7×	2.8k 0.3×	3.7k 0.6×	1.7k 0.4×	268	17.0k
Allen M. Gown United States	68	5.0k 0.4×	3.8k 0.3×	3.7k 0.4×	6.4k 1.0×	2.2k 0.5×	191	16.1k
Silvana Pilotti Italy	68	5.1k 0.4×	5.3k 0.5×	2.7k 0.3×	6.6k 1.0×	2.7k 0.6×	294	16.2k
Gilles Thomas France	62	6.5k 0.5×	4.5k 0.4×	2.7k 0.3×	4.1k 0.6×	1.8k 0.4×	248	16.1k
Hiroyuki Mano Japan	66	9.4k 0.7×	8.5k 0.8×	4.6k 0.5×	8.4k 1.3×	950 0.2×	262	19.5k

Countries citing papers authored by Pedram Argani

Since Specialization

Citations

This map shows the geographic impact of Pedram Argani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedram Argani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedram Argani more than expected).

Fields of papers citing papers by Pedram Argani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedram Argani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedram Argani. The network helps show where Pedram Argani may publish in the future.

Co-authorship network of co-authors of Pedram Argani

This figure shows the co-authorship network connecting the top 25 collaborators of Pedram Argani. A scholar is included among the top collaborators of Pedram Argani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedram Argani. Pedram Argani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Huili, et al.. (2025). Examination of the histogenesis of epithelial cysts in angiomyolipoma with epithelial cysts (AMLEC) using GPNMB and TSC2 immunostains. Human Pathology. 157. 105764–105764. 1 indexed citations

Ahlawat, Shivani, et al.. (2024). Case report: MEK inhibitor as treatment for multi-lineage mosaic KRAS G12D-associated epidermal nevus syndrome in a pediatric patient. Frontiers in Neurology. 15. 1466946–1466946. 2 indexed citations

Wei, Shuanzeng, Daniel M. Geynisman, Andrew Elliott, et al.. (2023). Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas. Modern Pathology. 37(2). 100404–100404. 7 indexed citations

Lee, Jae W., Yang Zhang, Tadashi Yoshizawa, et al.. (2022). Cancerization of ducts in hilar cholangiocarcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 1–10. 3 indexed citations

Asrani, Kaushal, Juhyung Woo, Adrianna A. Mendes, et al.. (2022). An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss. Nature Communications. 13(1). 6808–6808. 26 indexed citations

Salles, Daniela C., Kaushal Asrani, Juhyung Woo, et al.. (2022). GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms. The Journal of Pathology. 257(2). 158–171. 61 indexed citations

Ščupáková, Klára, Benjamin Balluff, Vinay Ayyappan, et al.. (2021). Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. JCI Insight. 6(24). 62 indexed citations

Wangsiricharoen, Sintawat, Minghao Zhong, Sarangarajan Ranganathan, Andrés Matoso, & Pedram Argani. (2021). ALK -rearranged Renal Cell Carcinoma (RCC): A Report of 2 Cases and Review of the Literature Emphasizing the Distinction Between VCL-ALK and Non- VCL-ALK RCC. International Journal of Surgical Pathology. 29(7). 808–814. 20 indexed citations

Luchini, Claudio, Scott Robertson, Seung‐Mo Hong, et al.. (2017). PBRM1 loss is a late event during the development of cholangiocarcinoma. Histopathology. 71(3). 375–382. 23 indexed citations

10.

Kao, Yu‐Chien, Yun-Shao Sung, Lei Zhang, et al.. (2016). Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy. The American Journal of Surgical Pathology. 40(8). 1009–1020. 139 indexed citations

11.

Samols, Mark A., Mohammed Lilo, Andrea P. Subhawong, et al.. (2014). NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. Journal of Clinical Pathology. 67(9). 768–771. 22 indexed citations

12.

Miao, Yu Rebecca, Bedrich L. Eckhardt, Yuan Cao, et al.. (2013). Inhibition of Established Micrometastases by Targeted Drug Delivery via Cell Surface–Associated GRP78. Clinical Cancer Research. 19(8). 2107–2116. 60 indexed citations

13.

Kleer, Celina G., Noga Bloushtain-Qimron, Yu‐Hui Chen, et al.. (2008). Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Clinical Cancer Research. 14(17). 5357–5367. 80 indexed citations

14.

Álvarez, Héctor M., Alejandro H. Corvalán, Juan Carlos Roa, et al.. (2008). Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer. Clinical Cancer Research. 14(9). 2631–2638. 33 indexed citations

15.

Tsuda, Masumi, Ian J. Davis, Pedram Argani, et al.. (2007). TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition. Cancer Research. 67(3). 919–929. 217 indexed citations

16.

Al‐Abbadi, Mousa A., Walid Abuhammour, Husain A. Saleh, et al.. (2005). Pediatrics. Modern Pathology. 18. 303–307. 1 indexed citations

17.

Hansel, Donna E., Ayman Rahman, Manuel Hidalgo, et al.. (2003). Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology. American Journal Of Pathology. 163(1). 217–229. 109 indexed citations

18.

Argani, Pedram, et al.. (2002). Renal cell carcinomas with t(X;1)(p11.2;q21): detailed morphologic, immunohistochemical, ultrastructural and molecular analysis of a cytogenetically-defined entity. Laboratory Investigation. 82. 1 indexed citations

19.

Argani, Pedram, Cristina R. Antonescu, Jérôme Couturier, et al.. (2002). PRCC-TFE3 Renal Carcinomas. The American Journal of Surgical Pathology. 26(12). 1553–1566. 259 indexed citations

20.

Lee, Maxwell P., Lawrence R. Lustig, Gordon F. Tomaselli, et al.. (2000). Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. Journal of Clinical Investigation. 106(12). 1447–1455. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact